SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CJ2'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S2A_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 12 | TYR A 24LEU A 54HIS A 117GLU A 192TYR A 216SER A 217TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 0.71A | 1s2aA-6f2uA:52.3 | 1s2aA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S2A_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24LEU A 54TRP A 86HIS A 117SER A 118GLU A 192TYR A 216SER A 217GLN A 222PHE A 306 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)NAP A 401 (-3.8A)CJ2 A 402 (-3.8A) | 0.45A | 1s2aA-6f2uA:52.3 | 1s2aA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S2A_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24LEU A 54TRP A 86HIS A 117SER A 118MET A 120GLU A 192TYR A 216SER A 217GLN A 222 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)NAP A 401 (-3.8A) | 0.36A | 1s2aA-6f2uA:52.3 | 1s2aA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XF0_A_ASDA600_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 9 | LEU A 54TRP A 86ASN A 167TRP A 227PRO A 318 | NoneNoneNAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)None | 1.22A | 1xf0A-6f2uA:50.8 | 1xf0A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XF0_A_ASDA600_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 9 | LEU A 54TRP A 86MET A 120ASN A 167TYR A 216PRO A 318 | NoneNoneCJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)None | 0.33A | 1xf0A-6f2uA:50.8 | 1xf0A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XF0_A_ASDA600_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 9 | LEU A 54TRP A 86MET A 120SER A 129ASN A 167PRO A 318 | NoneNoneCJ2 A 402 ( 4.7A)NoneNAP A 401 ( 3.3A)None | 0.62A | 1xf0A-6f2uA:50.8 | 1xf0A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XF0_A_ASDA600_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 9 | LEU A 54TRP A 86SER A 129ASN A 167PHE A 306 | NoneNoneNoneNAP A 401 ( 3.3A)CJ2 A 402 (-3.8A) | 1.41A | 1xf0A-6f2uA:50.8 | 1xf0A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F38_A_15MA325_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 12 | TRP A 86SER A 118PHE A 311PRO A 318TYR A 317 | NoneCJ2 A 402 ( 3.7A)NoneNoneNone | 1.39A | 2f38A-6f2uA:52.2 | 2f38A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F38_A_15MA325_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24TRP A 86SER A 118MET A 120LEU A 122SER A 129ASN A 167PHE A 306PRO A 318TYR A 319 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NoneNoneNAP A 401 ( 3.3A)CJ2 A 402 (-3.8A)NoneNone | 0.52A | 2f38A-6f2uA:52.2 | 2f38A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F38_A_15MA325_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24TRP A 86SER A 118MET A 120LEU A 122SER A 129ASN A 167PHE A 311PRO A 318TYR A 319 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NoneNoneNAP A 401 ( 3.3A)NoneNoneNone | 0.61A | 2f38A-6f2uA:52.2 | 2f38A-6f2uA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GVC_B_MMZB501_1 (MONOOXYGENASE) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 3 / 3 | ASN A 189TYR A 319SER A 118 | NoneNoneCJ2 A 402 ( 3.7A) | 0.93A | 2gvcB-6f2uA:undetectable | 2gvcB-6f2uA:13.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BWC_A_SAMA501_0 (SPERMIDINE SYNTHASE) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 12 | HIS A 117ILE A 163GLY A 164VAL A 214ASP A 12 | CJ2 A 402 ( 3.8A)NoneNoneNoneNone | 1.04A | 3bwcA-6f2uA:undetectable | 3bwcA-6f2uA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSK_C_ACTC901_0 (PYRANOSE 2-OXIDASE) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 4 / 5 | SER A 118GLN A 172HIS A 314ASN A 316 | CJ2 A 402 ( 3.7A)NoneNoneNone | 1.46A | 3lskC-6f2uA:0.9 | 3lskC-6f2uA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R43_A_ID8A332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 12 | LEU A 54TYR A 55HIS A 117SER A 118ASN A 167TRP A 227PHE A 306 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 1.07A | 3r43A-6f2uA:51.5 | 3r43A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R43_A_ID8A332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 12 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 87 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)None | 1.43A | 3r43A-6f2uA:51.5 | 3r43A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R43_A_ID8A332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118ASN A 167TYR A 216TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)CJ2 A 402 ( 4.8A) | 0.55A | 3r43A-6f2uA:51.5 | 3r43A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R43_A_ID8A332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118MET A 120ASN A 167TYR A 216 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A) | 0.28A | 3r43A-6f2uA:51.5 | 3r43A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R58_A_NPSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 10 | LEU A 54TYR A 55HIS A 117ASN A 167PHE A 306PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A)CJ2 A 402 (-3.8A)NoneNone | 1.08A | 3r58A-6f2uA:50.2 | 3r58A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R58_A_NPSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 10 | LEU A 54TYR A 55HIS A 117MET A 120ASN A 167TYR A 216PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)NoneNone | 0.37A | 3r58A-6f2uA:50.2 | 3r58A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R6I_A_JMSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 12 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 87 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)None | 1.47A | 3r6iA-6f2uA:50.4 | 3r6iA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R6I_A_JMSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 12 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 118ASN A 167TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 1.04A | 3r6iA-6f2uA:50.4 | 3r6iA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R6I_A_JMSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118ASN A 167TYR A 216TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)CJ2 A 402 ( 4.8A) | 0.48A | 3r6iA-6f2uA:50.4 | 3r6iA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R6I_A_JMSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118MET A 120ASN A 167TYR A 216 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A) | 0.27A | 3r6iA-6f2uA:50.4 | 3r6iA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R7M_A_SUZA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 10 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 118ASN A 167TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 1.03A | 3r7mA-6f2uA:50.3 | 3r7mA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R7M_A_SUZA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 10 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118ASN A 167TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A) | 0.48A | 3r7mA-6f2uA:50.3 | 3r7mA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R8G_A_IZPA409_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 9 | LEU A 54TYR A 55HIS A 117ASN A 167PHE A 306PRO A 318 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A)CJ2 A 402 (-3.8A)None | 1.06A | 3r8gA-6f2uA:50.5 | 3r8gA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R8G_A_IZPA409_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 9 | LEU A 54TYR A 55HIS A 117MET A 120ASN A 167TYR A 216PRO A 318 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)None | 0.34A | 3r8gA-6f2uA:50.5 | 3r8gA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R94_A_FLRA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | LEU A 54TYR A 55HIS A 117SER A 118ASN A 167TRP A 227PHE A 306PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A)NoneNone | 1.07A | 3r94A-6f2uA:50.2 | 3r94A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R94_A_FLRA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | LEU A 54TYR A 55HIS A 117SER A 118ASN A 167TYR A 216TRP A 227PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)CJ2 A 402 ( 4.8A)NoneNone | 0.49A | 3r94A-6f2uA:50.2 | 3r94A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R94_A_FLRA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | LEU A 54TYR A 55HIS A 117SER A 118MET A 120ASN A 167TYR A 216PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)NoneNone | 0.35A | 3r94A-6f2uA:50.2 | 3r94A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | LEU A 54TRP A 86MET A 120SER A 217PRO A 318TYR A 319 | NoneNoneCJ2 A 402 ( 4.7A)NAP A 401 ( 2.7A)NoneNone | 1.14A | 3ug8A-6f2uA:50.6 | 3ug8A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 11 / 12 | LEU A 54TYR A 55TRP A 86HIS A 117MET A 120ASN A 167TYR A 216SER A 217SER A 221PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 (-4.6A)NoneNone | 0.39A | 3ug8A-6f2uA:50.6 | 3ug8A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TRP A 86MET A 120ASN A 167TYR A 216SER A 217SER A 221PHE A 306PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 (-4.6A)CJ2 A 402 (-3.8A)NoneNone | 0.72A | 3ug8A-6f2uA:50.6 | 3ug8A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | TRP A 86MET A 120SER A 217PHE A 306PRO A 318TYR A 319 | NoneCJ2 A 402 ( 4.7A)NAP A 401 ( 2.7A)CJ2 A 402 (-3.8A)NoneNone | 1.08A | 3ug8A-6f2uA:50.6 | 3ug8A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_2 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 3 / 3 | TYR A 24GLU A 192TYR A 305 | CJ2 A 402 (-4.2A)CJ2 A 402 ( 3.8A)None | 0.23A | 3ug8A-6f2uA:50.6 | 3ug8A-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 12 | TYR A 24LEU A 54HIS A 117TYR A 216SER A 217SER A 221TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 3.8A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 (-4.6A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 0.76A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 12 | TYR A 24LEU A 54SER A 217TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneNAP A 401 ( 2.7A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 1.45A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TRP A 86HIS A 117SER A 118MET A 120TYR A 216SER A 217SER A 221 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 (-4.6A) | 0.40A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TRP A 86HIS A 117SER A 118TYR A 216SER A 217SER A 221PHE A 306 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.2A)NAP A 401 ( 2.7A)CJ2 A 402 (-4.6A)CJ2 A 402 (-3.8A) | 0.47A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | TYR A 24LEU A 54TRP A 86SER A 118MET A 120SER A 217 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 2.7A) | 1.04A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | TYR A 24LEU A 54TRP A 86SER A 118SER A 217PHE A 306 | CJ2 A 402 (-4.2A)NoneNoneCJ2 A 402 ( 3.7A)NAP A 401 ( 2.7A)CJ2 A 402 (-3.8A) | 1.31A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_2 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 7 | TYR A 55ASN A 167GLU A 192GLN A 222TYR A 305PRO A 318TYR A 319 | CJ2 A 402 ( 4.1A)NAP A 401 ( 3.3A)CJ2 A 402 ( 3.8A)NAP A 401 (-3.8A)NoneNoneNone | 0.37A | 3ugrA-6f2uA:51.1 | 3ugrA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JQ4_B_IMNB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 10 | TYR A 24TYR A 55HIS A 117ASN A 167TYR A 216 | CJ2 A 402 (-4.2A)CJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A) | 0.28A | 4jq4B-6f2uA:50.5 | 4jq4B-6f2uA:92.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JTR_A_IBPA401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 4 / 8 | TYR A 24TYR A 55TRP A 86HIS A 117 | CJ2 A 402 (-4.2A)CJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A) | 0.19A | 4jtrA-6f2uA:51.5 | 4jtrA-6f2uA:92.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JTR_B_IZPB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 4 / 6 | TYR A 24TYR A 55TRP A 86HIS A 117 | CJ2 A 402 (-4.2A)CJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A) | 0.27A | 4jtrB-6f2uA:51.6 | 4jtrB-6f2uA:92.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVP_A_GBMA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C1) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 5 / 11 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A) | 0.29A | 4yvpA-6f2uA:51.2 | 4yvpA-6f2uA:96.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVP_B_GBMB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C1) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117ASN A 167 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A) | 0.23A | 4yvpB-6f2uA:51.5 | 4yvpB-6f2uA:96.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVV_A_GBMA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 9 | LEU A 54TYR A 55TRP A 86HIS A 117ASN A 167TYR A 216TRP A 227 | NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A)CJ2 A 402 ( 4.8A) | 1.34A | 4yvvA-6f2uA:52.8 | 4yvvA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVV_A_GBMA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 7 / 9 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117ASN A 167TYR A 216 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)NAP A 401 ( 3.3A)NAP A 401 ( 3.2A) | 0.18A | 4yvvA-6f2uA:52.8 | 4yvvA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVV_B_GBMB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 9 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 87TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)NoneCJ2 A 402 ( 4.8A) | 1.46A | 4yvvB-6f2uA:52.8 | 4yvvB-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVV_B_GBMB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 9 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118ASN A 167TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A) | 0.82A | 4yvvB-6f2uA:52.8 | 4yvvB-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_A_GMRA401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 9 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118ASN A 167TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 0.92A | 4yvxA-6f2uA:52.8 | 4yvxA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_A_GMRA401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118LEU A 122SER A 129ASN A 167PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)NoneNoneNAP A 401 ( 3.3A)CJ2 A 402 (-3.8A) | 0.49A | 4yvxA-6f2uA:52.8 | 4yvxA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_B_GMRB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 6 / 12 | TYR A 24LEU A 54TYR A 55HIS A 117SER A 87TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)CJ2 A 402 ( 3.8A)NoneCJ2 A 402 ( 4.8A) | 1.49A | 4yvxB-6f2uA:53.0 | 4yvxB-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_B_GMRB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 10 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118MET A 120ASN A 167TRP A 227PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A)CJ2 A 402 (-3.8A) | 0.82A | 4yvxB-6f2uA:53.0 | 4yvxB-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_B_GMRB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 11 / 12 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117SER A 118MET A 120LEU A 122SER A 129ASN A 167PHE A 306 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 3.7A)CJ2 A 402 ( 4.7A)NoneNoneNAP A 401 ( 3.3A)CJ2 A 402 (-3.8A) | 0.34A | 4yvxB-6f2uA:53.0 | 4yvxB-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZFC_A_GCZA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 9 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117MET A 120ASN A 167TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A) | 1.08A | 4zfcA-6f2uA:53.0 | 4zfcA-6f2uA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZFC_B_GCZB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
6f2u | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3 (Homosapiens) | 8 / 9 | TYR A 24LEU A 54TYR A 55TRP A 86HIS A 117MET A 120ASN A 167TRP A 227 | CJ2 A 402 (-4.2A)NoneCJ2 A 402 ( 4.1A)NoneCJ2 A 402 ( 3.8A)CJ2 A 402 ( 4.7A)NAP A 401 ( 3.3A)CJ2 A 402 ( 4.8A) | 1.04A | 4zfcB-6f2uA:52.8 | 4zfcB-6f2uA:100.00 |